CONTRACT HHSN272201800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE I AND II CLINICAL TESTING INTERNATIONAL AIDS VACCINE INITIATIVE INC. $8,337,685 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Sep 26, 2023 Sep 26, 2023 Dec 31, 2026
PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS INTERNATIONAL AIDS VACCINE INITIATIVE INC. $8,398,301 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Dec 1, 2021 Dec 1, 2021 Aug 29, 2030
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN INTERNATIONAL AIDS VACCINE INITIATIVE INC. $166,898,763 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN42 HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH Sep 30, 2021 Sep 30, 2021 Nov 30, 2027
HHSN272201800010I IAVI STORAGE OF GMP AND NON-GMP MATERIALS FOR NIAID BASE AWARD, CAN 8470038 FOR $435,313.50 CAN 8040917 FOR $435,313.50 TOTAL $870,627 INTERNATIONAL AIDS VACCINE INITIATIVE INC. $870,627 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Sep 14, 2021 Sep 14, 2021 May 14, 2028
THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE SURFACE OF THE LNP. A NON-GMP PROCESS RUN OF DRUG PRODUCT SHALL BE PERF INTERNATIONAL AIDS VACCINE INITIATIVE INC. $2,250,744 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN11 HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH Aug 31, 2021 Sep 15, 2021 Aug 31, 2028
COORDINATION AND TECHNICAL SUPPORT INTERNATIONAL AIDS VACCINE INITIATIVE INC. $177,790 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN11 HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH Jul 7, 2021 Jul 15, 2021 Jul 14, 2023
ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM INTERNATIONAL AIDS VACCINE INITIATIVE INC. $26,261,466 DEFENSE THREAT REDUCTION AGENCY (DTRA) DEFENSE THREAT REDUCTION AGENCY (DTRA) — 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) AC33 NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; EXPERIMENTAL DEVELOPMENT Oct 5, 2020 Oct 5, 2020 Dec 4, 2024
1800010I IAVI BASE AWARD $810,077 FY20 CELL LINE OPTIMIZATION AND PRE-MASTER BANK GENERATION FOR SB 301, A VACCINE FOR HEPATITIS B VIRUS (HBV) TOVM20V24VB 2 IID CAN 8470036 INTERNATIONAL AIDS VACCINE INITIATIVE INC. $1,098,404 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Sep 22, 2020 Sep 22, 2020 May 14, 2028
COORDINATION AND TECHNICAL SUPPORT INTERNATIONAL AIDS VACCINE INITIATIVE INC. $1,327,640 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Jul 10, 2020 Jul 15, 2020 Jul 14, 2021
IAVI BASE AWARD FY20 MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS COVID-19 CAN 8044363 $21,065.00 INTERNATIONAL AIDS VACCINE INITIATIVE INC. $21,065 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH May 8, 2020 May 8, 2020 May 14, 2028
INTERNATIONAL AIDS VACCINE INITIATIVE FY20 BASE AWARD PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS COV 2 COV CAN 8044363 TOTAL $20,264.00 INTERNATIONAL AIDS VACCINE INITIATIVE INC. $20,264 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH May 8, 2020 May 8, 2020 Apr 17, 2025
ANTIGEN-ADJUVANT FORMULATION AND CHARACTERIZATION STUDIES INTERNATIONAL AIDS VACCINE INITIATIVE INC. $978,729 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Aug 23, 2019 Aug 30, 2019 Apr 16, 2021
PROCESS DEVELOPMENT FOR CELL CULTURE, UPSTREAM AND DOWNSTREAM PROCESS IN PRODUCTION OF HIV-1 BIOMOLECULES INTERNATIONAL AIDS VACCINE INITIATIVE INC. $1,707,175 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Aug 12, 2019 Aug 15, 2019 Apr 16, 2021
NANOPARTICLE-BASED DEVELOPMENT FOR HIV-1 BIOMOLECULE DELIVERY INTERNATIONAL AIDS VACCINE INITIATIVE INC. $713,906 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Aug 9, 2019 Aug 15, 2019 Dec 15, 2021
PROCESS AND ASSAY DEVELOPMENT FOR CGMP PRODUCTION AND CHARACTERIZATION OF A VSV CANDIDATE INTERNATIONAL AIDS VACCINE INITIATIVE INC. $2,815,707 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Aug 8, 2019 Aug 8, 2019 Aug 30, 2022
COORDINATION AND TECHNICAL SUPPORT INTERNATIONAL AIDS VACCINE INITIATIVE INC. $3,170,861 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Jul 11, 2019 Jul 15, 2019 Jul 14, 2020
1800010I INTERNATIONAL AIDS VACCINE INITIATIVE TO V3 OBRA--2 BASE TASK ORDER FUNDING BIOD CAN 8470038 $642,953 INTERNATIONAL AIDS VACCINE INITIATIVE INC. $3,828,720 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Feb 28, 2019 Feb 28, 2019 Sep 30, 2026
1800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF HUMAN FLU CHALLENGE MATERIAL INTERNATIONAL AIDS VACCINE INITIATIVE INC. $26,065,720 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH Aug 28, 2018 Aug 28, 2018 May 14, 2028
1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; TO V1 OBRA--2 BASE TASK ORDER FUNDING; BIOD CAN 8470038 $60,322 INTERNATIONAL AIDS VACCINE INITIATIVE INC. $55,936 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541714 Research and Development in Biotechnology (except Nanobiotechnology) AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH May 15, 2018 May 15, 2018 May 14, 2019
IGF::OT::IGF PRODUCT DEVELOPMENT PLANS TO SUPPORT HIV VACCINE MANUFACTURING EFFORTS INTERNATIONAL AIDS VACCINE INITIATIVE INC. $110,751 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Sep 19, 2017 Sep 19, 2017 Feb 28, 2019
IGF::OT::IGF PRODUCT DEVELOPMENT PLANS TO SUPPORT HIV VACCINE MANUFACTURING EFFORTS INTERNATIONAL AIDS VACCINE INITIATIVE INC. $105,353 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Sep 19, 2017 Sep 19, 2017 Sep 19, 2018
IGF::OT::IGF FEASIBILITY ASSESSMENT OF HIV ENV PROTEIN ANTIGENS INTERNATIONAL AIDS VACCINE INITIATIVE INC. $432,452 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Sep 14, 2017 Sep 14, 2017 Oct 31, 2018
IGF::OT::IGF STAGED VACCINE DEVELOPMENT: IMMUNOPROPHYLAXIS BY GENE TRANSFER INTERNATIONAL AIDS VACCINE INITIATIVE INC. $13,086,898 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Dec 22, 2016 Dec 22, 2016 Jan 31, 2026
IGF::OT::IGF ANALYSIS OF HIV-1 ENV HOST CELL PROTEINS BY MASS SPECTROMETRY METHOD INTERNATIONAL AIDS VACCINE INITIATIVE INC. $508,433 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Sep 21, 2016 Sep 21, 2016 Mar 21, 2018
IGF::OT::IGF PURIFICATION OF HIV ENV PROTEINS WITH AN IMMUNOAFFINITY BASED PROCESS INTERNATIONAL AIDS VACCINE INITIATIVE INC. $1,572,742 NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH — 541712 AN81 Sep 20, 2016 Sep 20, 2016 Jun 15, 2020